Learned spatial expression mode associates with treatment response in a small cohort
Source check: Source checked. Not independent scientific confirmation.
Finding: An unsupervised spatial-learning model fitted 20 expression modes in pretreatment samples from 21 cutaneous squamous-cell-cancer patients. A subsequently selected mode showed greater neighboring-cell contrast in responders than non-responders. This is an exploratory same-cohort spatial association, not an independently validated treatment-response predictor.
Technology: SAIL; unsupervised sparse spatial projection learning
Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Learned sparse projections optimize spatial coherence rather than simply plotting coordinates. The resulting mode supplies the patient-level contrast examined against recorded response.
- Test and result
- Spatial modes were fitted without response labels from 28 pretreatment biopsies in 21 patients. Response comparisons subsequently selected the most discriminative of 20 modes.
- Limitation / still unknown
- Post-training mode selection uses the same 21 response labels. Nominal comparisons across 20 modes do not establish multiplicity-adjusted confirmation or held-out predictive accuracy. Prior work already linked spatial organization to response; this refinement does not establish a causal immune mechanism or treatment benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://arxiv.org/html/2610.28806v1 · https://arxiv.org/abs/2610.28806v1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 21 Nov 2026. Review scope: Original v1 front, computational objectiveIII-C, clinical applicationV-D and statistical limitations; no operational laboratory protocols.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.